Literature DB >> 28663146

Human nonsense-mediated RNA decay regulates EMT by targeting the TGF-ß signaling pathway in lung adenocarcinoma.

Lu Cao1, Lisha Qi1, Lin Zhang2, Wangzhao Song1, Yue Yu3, Cong Xu1, Lingmei Li1, Yuhong Guo1, Lingyi Yang1, Changxu Liu1, Qiujuan Huang1, Yalei Wang1, Baocun Sun1, Bin Meng1, Bin Zhang4, Wenfeng Cao5.   

Abstract

Nonsense-mediated mRNA decay (NMD) is a highly conserved pathway that selectively degrades aberrant RNA transcripts. In this study, we proved that NMD regulates the epithelial-mesenchymal transition (EMT) of lung adenocarcinoma (ADC). Moreover, we found that NMD core factor UP-frameshift 1 tends to be expressed at lower levels in human ADC tissues than in normal lung tissues, thereby raising the possibility that NMD may be downregulated to permit ADC oncogenesis. Our experiments in human ADC cell lines showed that downregulating NMD can promote EMT. Moreover, EMT can be inhibited by upregulating NMD. We tested the role of TGF-ß signaling and found that NMD influences EMT by targeting the TGF-ß signaling pathway. Our findings reveal that NMD is a potential tumor regulatory mechanism and may be a potential therapeutic target for ADC.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  EMT; Lung adenocarcinoma; Nonsense-mediated mRNA decay; TGF-ß; UPF1

Mesh:

Substances:

Year:  2017        PMID: 28663146     DOI: 10.1016/j.canlet.2017.06.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

Review 1.  Nonsense-mediated mRNA Decay and Cancer.

Authors:  Maximilian W Popp; Lynne E Maquat
Journal:  Curr Opin Genet Dev       Date:  2017-11-07       Impact factor: 5.578

Review 2.  Nonsense-mediated RNA decay: an emerging modulator of malignancy.

Authors:  Kun Tan; Dwayne G Stupack; Miles F Wilkinson
Journal:  Nat Rev Cancer       Date:  2022-05-27       Impact factor: 69.800

3.  WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.

Authors:  Baohua Li; Xuedong Guo; Na Li; Qin Chen; Junhua Shen; Xiaoxiu Huang; Genping Huang; Fenfen Wang
Journal:  Cell Oncol (Dordr)       Date:  2020-04-16       Impact factor: 6.730

4.  AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.

Authors:  Lu Cao; Cong Xu; Guomin Xiang; Fang Liu; Xiaozhen Liu; Congying Li; Jing Liu; Qingxiang Meng; Jiao Jiao; Yun Niu
Journal:  Mol Cancer       Date:  2018-09-14       Impact factor: 27.401

5.  UPF1 inhibits the hepatocellular carcinoma progression by targeting long non-coding RNA UCA1.

Authors:  Yongli Zhou; Yandong Li; Na Wang; Xiuying Li; Jianyun Zheng; Liqiao Ge
Journal:  Sci Rep       Date:  2019-04-30       Impact factor: 4.379

6.  Amorphous silica nanoparticles induce tumorigenesis via regulating ATP5H/SOD1-related oxidative stress, oxidative phosphorylation and EIF4G2/PABPC1-associated translational initiation.

Authors:  Dongli Xie; Yang Zhou; Xiaogang Luo
Journal:  PeerJ       Date:  2019-03-04       Impact factor: 2.984

Review 7.  Nonsense-mediated RNA decay and its bipolar function in cancer.

Authors:  Gonçalo Nogueira; Rafael Fernandes; Juan F García-Moreno; Luísa Romão
Journal:  Mol Cancer       Date:  2021-04-29       Impact factor: 27.401

8.  Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1.

Authors:  Shuiyi Liu; Weiqun Chen; Hui Hu; Tianzhu Zhang; Tangwei Wu; Xiaoyi Li; Yong Li; Qinzhi Kong; Hongda Lu; Zhongxin Lu
Journal:  Breast Cancer Res       Date:  2021-12-18       Impact factor: 6.466

9.  UPF1 Participates in the Progression of Endometrial Cancer by Inhibiting the Expression of lncRNA PVT1.

Authors:  Tian-Rong Xing; Ping Chen; Jia-Mei Wu; Li-Li Gao; Wei Yang; Yu Cheng; Li-Bo Tong
Journal:  Onco Targets Ther       Date:  2020-03-09       Impact factor: 4.147

10.  The ubiquitin E3 ligase ARIH1 regulates hnRNP E1 protein stability, EMT and breast cancer progression.

Authors:  Breege V Howley; Bidyut Mohanty; Annamarie Dalton; Simon Grelet; Joseph Karam; Toros Dincman; Philip H Howe
Journal:  Oncogene       Date:  2022-01-31       Impact factor: 8.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.